PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 167 filers reported holding PRECIGEN INC in Q3 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,403 | -59.8% | 39,721 | -67.5% | 0.00% | – |
| Q2 2023 | $140,352 | +41.2% | 122,045 | +30.1% | 0.00% | – |
| Q1 2023 | $99,427 | +48.9% | 93,800 | +113.6% | 0.00% | – |
| Q4 2022 | $66,754 | -32.6% | 43,917 | -6.7% | 0.00% | – |
| Q3 2022 | $99,000 | +106.2% | 47,068 | +31.9% | 0.00% | – |
| Q2 2022 | $48,000 | -42.2% | 35,687 | -9.6% | 0.00% | – |
| Q1 2022 | $83,000 | -95.5% | 39,463 | -92.1% | 0.00% | -100.0% |
| Q4 2021 | $1,859,000 | +30.7% | 500,819 | +75.7% | 0.00% | – |
| Q3 2021 | $1,422,000 | +92.7% | 284,985 | +152.0% | 0.00% | – |
| Q2 2021 | $738,000 | -59.5% | 113,084 | -57.2% | 0.00% | -100.0% |
| Q1 2021 | $1,823,000 | -33.1% | 264,469 | -1.0% | 0.00% | 0.0% |
| Q4 2020 | $2,725,000 | +156.3% | 267,174 | -12.0% | 0.00% | – |
| Q3 2020 | $1,063,000 | +58.4% | 303,507 | +125.5% | 0.00% | – |
| Q2 2020 | $671,000 | +55.7% | 134,607 | +6.1% | 0.00% | – |
| Q1 2020 | $431,000 | – | 126,809 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |